CompletedNot Applicable

Safety and Efficacy of Meloxicam Compared to Other Nonsteroidal Antiinflammatory Drugs (NSAIDs) in an Observational Cohort Study of Patients With Rheumatoid Arthritis, Osteoarthritis, Lumbago, Scapulohumeral Periarthritis, Neck, Shoulder and Arm Syndrome

9,984 participantsStarted 2001-10

Plain-language summary

Study to assess the safety profile of meloxicam by comparing incidence of gastrointestinal adverse events of meloxicam with that of NSAID in the routine daily therapeutic situation.

Who can participate

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Patients with Indications according to the package insert of the prescribed NSAID Exclusion Criteria: * There is no exclusion criterion, because this Post Marketing Study is an observational study

What they're measuring

Incidence for adverse event of gastrointestinal disorder

Timeframe: up to 6 months

Trial details

NCT IDNCT02180516

SponsorBoehringer Ingelheim

Sponsor typeINDUSTRY

Study typeOBSERVATIONAL

Primary completion2004-09

View on ClinicalTrials.gov More Arthritis, Rheumatoid trials